Pharma Reviews: India's Shilpa Medicare to make Cadila's COVID-19 vaccine - The Economic Times

Reuters Shilpa Medicare said its unit will make the vaccine's drug substance, while Cadila will package, distribute and market the shot. Indian drugmaker.
Read more: India's Shilpa Medicare to make Cadila's COVID-19 vaccine - The Economic Times